Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Biotech
Zenas, Bicara set out to raise $180M-plus in separate IPOs
After revealing intentions to hit the public markets less than a month ago, Zenas and Bicara on Friday offered details behind their planned IPOs.
James Waldron
,
Eric Sagonowsky
Sep 6, 2024 8:18am
Duality seeks cash for ADC trials as IPO wave spreads to Asia
Aug 27, 2024 9:20am
MBX files for IPO to take challenger to Ascendis into phase 3
Aug 26, 2024 9:40am
Bicara, Zenas seek IPOs to push late-phase assets toward market
Aug 23, 2024 5:07am
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Aug 23, 2024 4:00am
Actuate is latest biotech on Nasdaq after $22.4M IPO
Aug 15, 2024 4:29am